Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.780
-0.100 (-3.47%)
At close: Mar 27, 2026, 4:00 PM EDT
2.750
-0.030 (-1.07%)
After-hours: Mar 27, 2026, 7:49 PM EDT
Absci Revenue
In the year 2025, Absci had annual revenue of $2.80M, down -38.24%. Absci had revenue of $650.00K in the quarter ending December 31, 2025, a decrease of -2.26%.
Revenue (ttm)
$2.80M
Revenue Growth
-38.24%
P/S Ratio
151.93
Revenue / Employee
$20,000
Employees
140
Market Cap
425.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.80M | -1.73M | -38.24% |
| Dec 31, 2024 | 4.53M | -1.18M | -20.71% |
| Dec 31, 2023 | 5.72M | -29.00K | -0.50% |
| Dec 31, 2022 | 5.75M | 965.00K | 20.18% |
| Dec 31, 2021 | 4.78M | 2.00K | 0.04% |
| Dec 31, 2020 | 4.78M | 2.72M | 132.04% |
| Dec 31, 2019 | 2.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maravai LifeSciences Holdings | 185.74M |
| Assembly Biosciences | 72.30M |
| Verastem | 30.91M |
| Crescent Biopharma | 10.84M |
| Aclaris Therapeutics | 7.83M |
| Shattuck Labs | 1.00M |
ABSI News
- 3 days ago - Absci: Downgrade To 'Hold' As ABS-101 On Back Burner And Pivot To ABS-201 - Seeking Alpha
- 3 days ago - Absci Corporation (ABSI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 5 days ago - Absci Corporation (ABSI) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript - Seeking Alpha
- 22 days ago - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Absci Corporation (ABSI) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 25 days ago - Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer - GlobeNewsWire
- 4 weeks ago - Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 - GlobeNewsWire